PMID: 696704Jan 1, 1978Paper

Illicit drug use and return to treatment: follow-up study of treatment admissions to DARP during 1969-1971

The American Journal of Drug and Alcohol Abuse
L J Savage, D Dwayne Simpson

Abstract

The present study was based on follow-up data on 1,409 persons interviewed 4 to 6 years after admission to drug treatments in the Drug Abuse Reporting Program (DARP). The admissions to DARP occurred in 1969-1971, and for most persons the follow-up data included 3 or more years after termination of DARP treatment. The focus of this study was on illicit drug use of former DARP clients, taking into account if and when they reentered drug treatment after termination of DARP treatment. The results showed that a significant drop in opioid and nonopioid (but not marijuana) drug use generally occurred upon entry into other, post-DARP treatments, and that these beneficial effects of treatment tended to continue beyond the end of treatment. Overall, 42% of the sample had no further drug treatment during the first 3 years after DARP, and almost half (42%) of this group used no opioid or nonopioid drugs at all during this time. Comparisons between DARP treatment groups also indicated that therapeutic community clients had the lowest rate of return to post-DARP treatments.

References


❮ Previous
Next ❯

Citations

Jul 1, 1991·Behavioral Sciences & the Law·M D Anglin, Y I Hser
Jan 5, 2000·Drug and Alcohol Dependence·M GossopA Rolfe
Dec 13, 2003·Journal of Substance Abuse Treatment·Christine E GrellaShih-Chao Hsieh
Dec 4, 2002·Addiction·Michael DennisUNKNOWN C. Y. T. Steering Committee
Jul 1, 1983·Journal of Psychoactive Drugs·G W Joe, D D Simpson
Jan 1, 1984·Journal of Psychoactive Drugs·W B O'Brien, D V Biase
Mar 1, 1992·British Journal of Addiction·D C Des Jarlais
Dec 1, 1991·The International Journal of the Addictions·D C Des JarlaisS Tross
Jan 1, 1992·The International Journal of the Addictions·V C CharuvastraW Ling
Sep 1, 1992·The International Journal of the Addictions·K Magruder-HabibH M Ginzburg
Oct 1, 1993·The International Journal of the Addictions·B S Brown
Apr 1, 1994·The International Journal of the Addictions·J L BleibergR Briscoe
Jul 1, 1982·The International Journal of the Addictions·D C Des Jarlais
Jun 1, 1985·The International Journal of the Addictions·B J Rounsaville, H D Kleber
Apr 1, 1982·The International Journal of the Addictions·B Y WhitmanJ McKay
Jan 1, 1982·The American Journal of Drug and Alcohol Abuse·G W JoeB K Singh
Jan 1, 1987·The American Journal of Drug and Alcohol Abuse·B J RounsavilleH D Kleber
Jan 1, 1980·The American Journal of Drug and Alcohol Abuse·D D SimpsonG W Joe
Jan 1, 1980·The American Journal of Drug and Alcohol Abuse·J F MadduxM Esquivel
Jan 1, 1981·The American Journal of Drug and Alcohol Abuse·L J Savage, D D Simpson
Jan 1, 1981·The American Journal of Drug and Alcohol Abuse·R H Coombs
Jan 1, 1981·The American Journal of Drug and Alcohol Abuse·D D Simpson, L J Savage
Jan 1, 1981·The American Journal of Drug and Alcohol Abuse·C Van RyswykR McGuire
Jan 1, 1982·The American Journal of Drug and Alcohol Abuse·R J Battjes
Jan 1, 1978·The American Journal of Drug and Alcohol Abuse·D D Simpson, M R Lloyd
Jan 1, 1991·The American Journal of Drug and Alcohol Abuse·D VlahovN Chowdhury
Jun 1, 1980·British Journal of Addiction·S B Sells, D D Simpson
Oct 1, 1981·Journal of Psychoactive Drugs·J J Hater, D D Simpson
Jun 13, 1998·Journal of Psychoactive Drugs·M A Eland-GoossensenH F Garretsen
Apr 1, 1991·Journal of Psychoactive Drugs·J Story, M J Stark
Jan 6, 2009·Journal of Social Work Practice in the Addictions·Megan SwanRoger Roffman
Jul 1, 1986·Journal of Psychoactive Drugs·H K Wexler, R Williams
Jan 1, 1984·The American Journal of Drug and Alcohol Abuse·A T McLellanG E Woody
Aug 1, 1984·Psychological Reports·S Graham-BafusJ R Gordon
Jan 1, 1987·Community Mental Health Journal·T L Scheid-Cook
Nov 1, 1992·The International Journal of the Addictions·W C McCaughrin, R H Price

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.